IMPACT OF OMALIZUMAB ON ALLERGIC ASTHMA - THE LAST 10 YEAR

M. Araújo Pereira (Braga, Portugal), I. Ladeira (Porto, Portugal), R. Lima (Porto, Portugal), I. Franco (Porto, Portugal), I. Pascoal (Porto, Portugal), A. Carvalho (Porto, Portugal)

Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session: Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type: Thematic Poster
Number: 1127
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Araújo Pereira (Braga, Portugal), I. Ladeira (Porto, Portugal), R. Lima (Porto, Portugal), I. Franco (Porto, Portugal), I. Pascoal (Porto, Portugal), A. Carvalho (Porto, Portugal). IMPACT OF OMALIZUMAB ON ALLERGIC ASTHMA - THE LAST 10 YEAR. 1127

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017


THE IMPACT OF REFLEXOLOGY AND HOMEOPATHY ADDED TO CONVENTIONAL ASTHMA TREATMENT ON MARKERS OF AIRWAY INFLAMMATION– A RANDOMISED STUDY
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


PREVALENCE AND SOCIOECONOMIC ASSOCIATIONS OF ASTHMA AND ALLERGIC RHINITIS IN NORTHERN AFRICA.
Source: Eur Respir J 2006; 28: 1292
Year: 2006


Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

DIFFERENCES IN HOSPITAL COURSE IN COMMUNITY ACQUIRED PNEUMONIA (CAP) ACCORDING TO ANTIBIOTIC TREATMENT
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019

AWAKE PRONE POSITION IN CRITICAL AND SEVERE COVID-19 PATIENTS UNDERGOING NONINVASIVE RESPIRATORY SUPPORT: A RETROSPECTIVE MULTICENTER COHORT STUDY.
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021


SCREENING FOR UNDERDIAGNOSED CHILDHOOD ASTHMA IN BATUMI (GEORGIA)
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020

CHARACTERIZATION AND SURVIVAL OF PATIENTS WITH SPINAL MUSCLE ATROPHY TYPE 1 ON HOME MECHANICAL VENTILATION PROGRAM OF MINISTRY OF HEALTH, CHILE
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017


BRONCHIOLITIS IN INFANCY IS AN IMPORTANT RISK FACTOR FOR ASTHMA BUT NOT FOR ALLERGIC SENSITIZATION AT AGE 6
Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors
Year: 2019

VENTILATORY MUSCLE STRENGTH SIX MONTHS AFTER CORONARY ARTERY BYPASS GRAFTING IN PATIENTS SUBMITTED TO INSPIRATORY MUSCULAR TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD: CLINICAL TRIAL
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021


IMPACT OF COMORBIDITY ON DIRECT MEDICAL COSTS OF COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017


INSPIRATORY MUSCLE TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD ON THE FUNCTIONAL CAPACITY OF PATIENTS SUBMITTED TO CORONARY ARTERIAL BYPASS GRAFTING: RANDOMIZED AND CONTROLLED CLINICAL TRIAL
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019


ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017


LYMPHANGIOLEIOMYOMATOSIS AND SIROLIMUS: MEDIUM-TERM IMPACT ON PULMONARY FUNCTION
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021


PROTEOMIC ANALYSIS OF BLOOD SERUM OF CHILDREN WITH BRONCHIAL ASTHMA
Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors
Year: 2019


IMPACT OF NON-INVASIVE VENTILATION IMMEDIATELY AFTER EXTUBATION ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS SUBMITTED TO CORONARY ARTERY BYPASS GRAFTING: CLINICAL TRIAL
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021


CARACTERISTICS OF A PROSPECTIVE COHORT OF PATIENTS WITH IPAF (INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES) BY NEUMOLOGISTS AND REUMATOLOGISTS OF MADRID. IPAF-NEREM STUDY
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON PULMONARY FUNCTION IN MIDDLE-AGE AND OLDER PATIENTS WITH TYPE 2 DIABETES
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

FOLLOW-UP OF OBSTRUCTIVE SLEEP APNEA TREATMENT: DIFFICULTIES FACED BY PRIMARY CARE UNITS
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


A STUDY OF CLINICORADIOLOGICAL AND MICROBIOLOGICAL PROFILE AND BIOMARKERS IN  CASES OF COMMUNITY ACQUIRED PNEUMONIA ADMITTED IN A TERTIARY CARE HOSPITAL
Source: Virtual Congress 2021 – Pneumonia
Year: 2021